Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Acute Pain in Burns
NCT03305055Phase 4Terminated
- Sponsor
- Johns Hopkins University
- Start
- Dec 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ketamine in acute pain, sponsored by Johns Hopkins University. Primary endpoint: Mean Wound Care Pain at 40 days. Started Dec 2017; status: terminated.
02
Drugs
ketamine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT03305055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03305055.